OXIDATIONSRESISTENTE AAT-GENTHERAPIE

European patent · EP3600345 · In force

Register entry

Publication number
EP3600345
Application number
EP18777905
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 29, 2018
Published
Feb 5, 2020
Granted
Jul 22, 2026
Protection ends at the latest
Mar 28, 2038
Next annual fee due
Mar 31, 2027
IPC classes
A61K 31/712 (2006.01)
A61K 48/00 (2006.01)
C07K 14/81 (2006.01)
C12N 15/00 (2006.01)
C12N 15/09 (2006.01)
C12N 15/63 (2006.01)
C12N 15/86 (2006.01)
Priority
US 201762478357 P 29.03.2017
PCT application
PCT/US2018/025183 29.03.2018
PCT publication
WO2018/183705 04.10.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.07.2026

Parties

Inventor

CRYSTAL, Ronald G.

New York, New York 10021, US

STILES, Katie

Bronx, New York 10461, US

SOSULSKI, Meredith

New York, New York 10028, US

KAMINSKY, Stephen M.

Bronx, New York 10471, US

SONDHI, Dolan

New York, New York 10023, US

DE, Bishnu

New Hyde Park, New York 11040, US

ROSENBERG, Jonathan

Cranbury, New Jersey 08512, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.